Langley, P. C. (2017). Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors. INNOVATIONS in Pharmacy, 8(2). https://doi.org/10.24926/iip.v8i2.516